Rigel Pharmaceuticals (RIGL) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.61% |
| Dec 31, 2025 | -8.48% |
| Sep 30, 2025 | -21.31% |
| Jun 30, 2025 | 3,519.60% |
| Mar 31, 2025 | -106.17% |
| Dec 31, 2024 | -33.22% |
| Sep 30, 2024 | 7,078.48% |
| Jun 30, 2024 | 106.02% |
| Mar 31, 2024 | 19.66% |
| Dec 31, 2023 | -359.16% |
| Sep 30, 2023 | -122.92% |
| Jun 30, 2023 | 245.56% |
| Mar 31, 2023 | 81.47% |
| Dec 31, 2022 | -62.95% |
| Sep 30, 2022 | -4.78% |
| Jun 30, 2022 | 50.21% |
| Mar 31, 2022 | -35.65% |
| Dec 31, 2021 | -82.14% |
| Sep 30, 2021 | -119.10% |
| Jun 30, 2021 | 373.69% |
| Mar 31, 2021 | -24.57% |
| Dec 31, 2020 | 18.30% |
| Sep 30, 2020 | -40.61% |
| Jun 30, 2020 | -278.22% |
| Mar 31, 2020 | 63.94% |
| Dec 31, 2019 | 31.57% |
| Sep 30, 2019 | 10.57% |
| Jun 30, 2019 | -1,672.30% |
| Mar 31, 2019 | -108.17% |
| Dec 31, 2018 | 157.19% |
| Sep 30, 2018 | 26.88% |
| Jun 30, 2018 | -17.32% |
| Mar 31, 2018 | -19.34% |
| Dec 31, 2017 | -11.90% |
| Sep 30, 2017 | 9.33% |
| Jun 30, 2017 | 6.34% |
| Mar 31, 2017 | -66.82% |
| Dec 31, 2016 | 45.36% |
| Sep 30, 2016 | -22.32% |
| Jun 30, 2016 | 17.95% |
| Mar 31, 2016 | -63.24% |
| Dec 31, 2015 | -42.68% |
| Sep 30, 2015 | 46.41% |
| Jun 30, 2015 | -201.47% |
| Mar 31, 2015 | 218.09% |
| Dec 31, 2014 | 17.09% |
| Sep 30, 2014 | 8.40% |
| Jun 30, 2014 | -20.55% |
| Mar 31, 2014 | 12.92% |
| Dec 31, 2013 | 8.63% |
| Sep 30, 2013 | 3.24% |
| Jun 30, 2013 | 16.35% |
| Mar 31, 2013 | -16.30% |
| Dec 31, 2012 | -10.81% |
| Sep 30, 2012 | 7.19% |
| Jun 30, 2012 | 13.24% |
| Mar 31, 2012 | -31.89% |
| Dec 31, 2011 | -41.07% |
| Sep 30, 2011 | 25.24% |
| Jun 30, 2011 | 17.39% |
| Mar 31, 2011 | -331.51% |
| Dec 31, 2010 | 146.92% |